Parcion Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parcion Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64M	Hold	12,854	–	–	0.1%	121
2025 Q4	$1.57M	Sell	12,854 -5,845	-31%	-$670K	0.1%	113
2025 Q3	$1.87M	Sell	18,699 -3,196	-15%	-$288K	0.12%	101
2025 Q2	$1.82M	Hold	21,895	–	–	0.13%	96
2025 Q1	$1.78M	Hold	21,895	–	–	0.14%	92
2024 Q4	$1.97M	Sell	21,895 -4,033	-16%	-$391K	0.15%	85
2024 Q3	$2.56M	Hold	25,928	–	–	0.21%	75
2024 Q2	$2.4M	Sell	25,928 -658	-2%	-$59K	0.22%	77
2024 Q1	$2.52M	Buy	+26,586	New	+$2.47M	0.22%	79

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parcion Private Wealth's XBI Position: Q1 2026 in Review

Parcion Private Wealth held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 12,854 shares worth $1.64M. The position accounts for 0.1% of the portfolio, ranked #121.

Parcion Private Wealth first reported a position in XBI in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.56M in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Parcion Private Wealth held 12,854 shares of State Street SPDR S&P Biotech ETF worth $1.64M as of Q1 2026.
Parcion Private Wealth left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.1% of Parcion Private Wealth's portfolio in Q1 2026, its #121 holding.
Parcion Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 9 quarters since.
Parcion Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $2.56M in Q3 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Parcion Private Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.